Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumor × cediranib × 1 year × Clear all

Sponsor

Conditions

Fallopian Tube Neoplasms 4 Ovarian Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Solitary Fibrous Tumor, Pleural 1 Small Cell Lung Carcinoma 1 Sarcoma, Alveolar Soft Part 1 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Melanoma 1 Leiomyosarcoma 1 Glioblastoma 1 Fallopian Tube Mucinous Adenocarcinoma 1 Colorectal Neoplasms 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1

Interventions

Injections 13 tislelizumab 9 pembrolizumab 9 toripalimab 7 atezolizumab 4 Nivolumab 4 Paclitaxel 3 Oxaliplatin 3 Fluorouracil 3 Carboplatin 3 Bevacizumab 3 trastuzumab deruxtecan 2 olaparib 2 lenvatinib 2 Pemetrexed 2 Leucovorin 2 Gemcitabine 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 zimberelimab 1 talazoparib 1 spartalizumab 1 serabelisib 1 penpulimab 1 niraparib 1 nedaplatin 1 fludarabine phosphate 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡